SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-122640
Filing Date
2024-04-29
Accepted
2024-04-29 16:46:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d232805ddefa14a.htm DEFA14A 12655
2 GRAPHIC g232805page007.jpg GRAPHIC 126975
3 GRAPHIC g232805page008.jpg GRAPHIC 93116
  Complete submission text file 0001193125-24-122640.txt   317080
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36274 | Film No.: 24891978
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)